| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.59 | 0.009 | 0.59 | GABA C receptor rho-3 antagonist | 0.42 0.053 CID_16304 | ||
| 0.571 | 0.009 | 0.571 | Calcium channel L-type activator | 0.507 0.025 CID_16304 | ||
| 0.545 | 0.019 | 0.545 | Aryl hydrocarbon receptor agonist | 0.51 0.023 CID_16304 | ||
| 0.535 | 0.02 | 0.535 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.533 0.021 CID_16304 | ||
| 0.471 | 0.012 | 0.471 | Peroxidase inhibitor | 0.188 0.063 CID_16304 | ||
| 0.429 | 0.005 | 0.429 | MAP kinase 9 inhibitor | |||
| 0.466 | 0.045 | 0.568 | 5 Hydroxytryptamine release inhibitor | 0.568 0.016 CID_16304 | CID_16304 | |
| 0.444 | 0.041 | 0.444 | Aldehyde oxidase inhibitor | 0.156 0.134 CID_16304 | ||
| 0.416 | 0.019 | 0.416 | Calcium channel activator | 0.31 0.082 CID_16304 | ||
| 0.431 | 0.04 | 0.431 | 5 Hydroxytryptamine release stimulant | 0.172 0.15 CID_16304 | ||
| 0.393 | 0.019 | 0.393 | RNA-directed DNA polymerase inhibitor | 0.263 0.043 CID_16304 | ||
| 0.405 | 0.037 | 0.453 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.453 0.027 CID_16304 | CID_16304 | |
| 0.376 | 0.031 | 0.376 | Superoxide dismutase inhibitor | 0.197 0.121 CID_16304 | ||
| 0.345 | 0.005 | 0.349 | Ferrochelatase inhibitor | 0.349 0.005 CID_16304 | CID_16304 | |
| 0.349 | 0.011 | 0.349 | Gastrin inhibitor | 0.343 0.012 CID_16304 | ||
| 0.354 | 0.017 | 0.354 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.196 0.08 CID_16304 | ||
| 0.355 | 0.023 | 0.355 | Anesthetic general | 0.345 0.025 CID_16304 | ||
| 0.34 | 0.013 | 0.34 | Protein-tyrosine kinase Lyn inhibitor | 0.129 0.078 CID_16304 | ||
| 0.342 | 0.017 | 0.342 | Protein kinase C nu inhibitor | |||
| 0.34 | 0.028 | 0.34 | 5 Hydroxytryptamine uptake stimulant | 0.261 0.071 CID_16304 | ||
| 0.314 | 0.005 | 0.314 | MAP kinase kinase 3 inhibitor | 0.188 0.163 CID_16304 | ||
| 0.336 | 0.028 | 0.336 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.181 0.107 CID_16304 | ||
| 0.312 | 0.007 | 0.312 | Carbonic anhydrase XV inhibitor | 0.229 0.014 CID_16304 | ||
| 0.382 | 0.085 | 0.473 | Histamine release inhibitor | 0.473 0.039 CID_16304 | CID_16304 | |
| 0.3 | 0.006 | 0.3 | MAP kinase 8 inhibitor | |||
| 0.309 | 0.016 | 0.309 | Lck kinase inhibitor | 0.158 0.061 CID_16304 | ||
| 0.301 | 0.009 | 0.301 | GABA C receptor agonist | 0.131 0.043 CID_16304 | ||
| 0.299 | 0.013 | 0.299 | Anesthetic local | 0.255 0.019 CID_16304 | ||
| 0.311 | 0.028 | 0.311 | Tyrosine 3 hydroxylase inhibitor | 0.26 0.059 CID_16304 | ||
| 0.293 | 0.017 | 0.564 | Alpha-N-acetylglucosaminidase inhibitor | 0.564 0.004 CID_16304 | CID_16304 | |
| 0.296 | 0.022 | 0.296 | LIM domain kinase 1 inhibitor | 0.242 0.042 CID_16304 | ||
| 0.298 | 0.024 | 0.298 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.278 0.031 CID_16304 | ||
| 0.325 | 0.058 | 0.396 | Interleukin 2 agonist | 0.396 0.029 CID_16304 | CID_16304 | |
| 0.347 | 0.084 | 0.347 | Prostaglandin dehydrogenase inhibitor | 0.255 0.124 CID_16304 | ||
| 0.28 | 0.018 | 0.28 | Heat shock protein 90 alpha antagonist | 0.23 0.034 CID_16304 | ||
| 0.27 | 0.008 | 0.27 | Mannose-6-phosphate isomerase inhibitor | 0.177 0.044 CID_16304 | ||
| 0.271 | 0.021 | 0.271 | Nitric-oxide synthase stimulant | 0.226 0.053 CID_16304 | ||
| 0.274 | 0.027 | 0.274 | Neurotrophic factor enhancer | 0.21 0.067 CID_16304 | ||
| 0.296 | 0.05 | 0.392 | Interleukin agonist | 0.392 0.02 CID_16304 | CID_16304 | |
| 0.286 | 0.04 | 0.286 | MAP kinase kinase 2 inhibitor | 0.222 0.068 CID_16304 | ||
| 0.295 | 0.049 | 0.295 | Pyruvate kinase inhibitor | 0.205 0.078 CID_16304 | ||
| 0.301 | 0.058 | 0.318 | Insulysin inhibitor | 0.318 0.048 CID_16304 | CID_16304 | |
| 0.279 | 0.042 | 0.279 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.339 | 0.106 | 0.339 | 15-Lipoxygenase inhibitor | 0.273 0.148 CID_16304 | ||
| 0.243 | 0.009 | 0.243 | DNA directed RNA polymerase inhibitor | |||
| 0.336 | 0.103 | 0.336 | MAP kinase kinase 6 inhibitor | |||
| 0.282 | 0.05 | 0.282 | DNA synthesis inhibitor | 0.2 0.124 CID_16304 | ||
| 0.253 | 0.024 | 0.253 | Phospholipase C inhibitor | 0.186 0.055 CID_16304 | ||
| 0.276 | 0.048 | 0.284 | 5 Hydroxytryptamine 1E antagonist | 0.284 0.041 CID_16304 | CID_16304 | |
| 0.237 | 0.014 | 0.237 | GABA C receptor rho-2 antagonist | 0.155 0.067 CID_16304 | ||
| 0.231 | 0.008 | 0.231 | Triose-phosphate isomerase inhibitor | 0.208 0.01 CID_16304 | ||
| 0.261 | 0.042 | 0.261 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.242 | 0.023 | 0.242 | Heat shock protein 90 antagonist | 0.169 0.056 CID_16304 | ||
| 0.306 | 0.087 | 0.306 | Cholesterol antagonist | 0.203 0.162 CID_16304 | ||
| 0.32 | 0.102 | 0.469 | Calpain 2 inhibitor | 0.469 0.033 CID_16304 | CID_16304 | |
| 0.237 | 0.023 | 0.281 | 5 Hydroxytryptamine 3E antagonist | 0.281 0.007 CID_16304 | CID_16304 | |
| 0.213 | 0.005 | 0.213 | NMDA 2C receptor antagonist | 0.126 0.009 CID_16304 | ||
| 0.217 | 0.01 | 0.217 | GABA C receptor antagonist | 0.118 0.055 CID_16304 | ||
| 0.219 | 0.013 | 0.219 | CF transmembrane conductance regulator agonist | 0.209 0.017 CID_16304 | ||
| 0.254 | 0.053 | 0.285 | Neuropeptide Y2 antagonist | 0.285 0.027 CID_16304 | CID_16304 | |
| 0.204 | 0.004 | 0.204 | GABA aminotransferase inhibitor | 0.116 0.018 CID_16304 | ||
| 0.218 | 0.021 | 0.218 | Cystathionine beta-synthase inhibitor | 0.12 0.058 CID_16304 | ||
| 0.203 | 0.009 | 0.203 | HIV-1 reverse transcriptase inhibitor | 0.062 0.056 CID_16304 | ||
| 0.338 | 0.144 | 0.519 | DNA directed DNA polymerase inhibitor | 0.519 0.077 CID_16304 | CID_16304 | |
| 0.231 | 0.04 | 0.231 | Lipocortins synthesis antagonist | |||
| 0.197 | 0.006 | 0.197 | Toll-Like receptor 3 antagonist | 0.115 0.034 CID_16304 | ||
| 0.197 | 0.009 | 0.197 | GABA C receptor rho-1 antagonist | 0.116 0.044 CID_16304 | ||
| 0.195 | 0.01 | 0.195 | Nitric-oxide synthase inhibitor | 0.091 0.075 CID_16304 | ||
| 0.224 | 0.039 | 0.284 | 3C-like protease (Human coronavirus) inhibitor | 0.284 0.015 CID_16304 | CID_16304 | |
| 0.22 | 0.035 | 0.22 | Protein kinase stimulant | 0.172 0.054 CID_16304 | ||
| 0.22 | 0.036 | 0.22 | Protein kinase (CK1) gamma 1 inhibitor | 0.141 0.076 CID_16304 | ||
| 0.193 | 0.013 | 0.193 | Porphobilinogen synthase inhibitor | 0.13 0.025 CID_16304 | ||
| 0.213 | 0.034 | 0.213 | Interleukin 6 antagonist | |||
| 0.191 | 0.013 | 0.191 | HIV-1 integrase (Overall Integration) inhibitor | 0.086 0.069 CID_16304 | ||
| 0.208 | 0.031 | 0.285 | Hexokinase inhibitor | 0.285 0.012 CID_16304 | CID_16304 | |
| 0.326 | 0.151 | 0.534 | DNA polymerase beta inhibitor | 0.534 0.077 CID_16304 | CID_16304 | |
| 0.182 | 0.007 | 0.182 | Biliverdin reductase inhibitor | 0.114 0.015 CID_16304 | ||
| 0.214 | 0.04 | 0.214 | Amylase inhibitor | |||
| 0.212 | 0.039 | 0.212 | Polo-like kinase-3 inhibitor | |||
| 0.19 | 0.017 | 0.207 | Sphingosine 1-phosphate receptor 5 antagonist | 0.207 0.009 CID_16304 | CID_16304 | |
| 0.183 | 0.01 | 0.199 | Electrolyte absorption antagonist | 0.199 0.008 CID_16304 | CID_16304 | |
| 0.233 | 0.061 | 0.233 | ErbB-1 antagonist | 0.182 0.112 CID_16304 | ||
| 0.182 | 0.011 | 0.182 | MAP kinase 11 inhibitor | 0.128 0.023 CID_16304 | ||
| 0.223 | 0.053 | 0.223 | I kappa B kinase epsilon inhibitor | 0.173 0.096 CID_16304 | ||
| 0.211 | 0.041 | 0.211 | Succinate dehydrogenase inhibitor | 0.192 0.056 CID_16304 | ||
| 0.19 | 0.019 | 0.224 | UDP-glucose 4-epimerase inhibitor | 0.224 0.015 CID_16304 | CID_16304 | |
| 0.182 | 0.012 | 0.182 | NADH dehydrogenase inhibitor | 0.104 0.04 CID_16304 | ||
| 0.203 | 0.034 | 0.211 | ATPase inhibitor | 0.211 0.029 CID_16304 | CID_16304 | |
| 0.216 | 0.048 | 0.216 | Histone acetyltransferase inhibitor | 0.171 0.112 CID_16304 | ||
| 0.201 | 0.034 | 0.201 | Neurotensin receptor agonist | 0.182 0.048 CID_16304 | ||
| 0.267 | 0.1 | 0.284 | 12-Lipoxygenase inhibitor | 0.284 0.089 CID_16304 | CID_16304 | |
| 0.215 | 0.048 | 0.215 | Src kinase inhibitor | 0.121 0.107 CID_16304 | ||
| 0.186 | 0.02 | 0.186 | 5 Hydroxytryptamine 3A agonist | |||
| 0.175 | 0.01 | 0.175 | Ca2+-transporting ATPase inhibitor | 0.153 0.037 CID_16304 | ||
| 0.199 | 0.034 | 0.199 | MAP kinase kinase 5 inhibitor | 0.16 0.114 CID_16304 | ||
| 0.214 | 0.051 | 0.267 | Growth factor agonist | 0.267 0.025 CID_16304 | CID_16304 | |
| 0.171 | 0.008 | 0.171 | Interleukin 12 antagonist | 0.127 0.023 CID_16304 | ||
| 0.178 | 0.015 | 0.245 | Sphingosine 1-phosphate receptor 4 antagonist | 0.245 0.005 CID_16304 | CID_16304 | |
| 0.178 | 0.016 | 0.212 | Sphingosine 1-phosphate receptor 2 antagonist | 0.212 0.005 CID_16304 | CID_16304 | |
| 0.309 | 0.15 | 0.472 | Transcription factor inhibitor | 0.472 0.084 CID_16304 | CID_16304 | |
| 0.196 | 0.037 | 0.196 | Arachidonic acid antagonist | 0.145 0.095 CID_16304 | ||
| 0.185 | 0.027 | 0.185 | Cathepsin H inhibitor | 0.162 0.038 CID_16304 | ||
| 0.177 | 0.019 | 0.177 | Photosensitizer | 0.115 0.063 CID_16304 | ||
| 0.174 | 0.018 | 0.174 | Gastric antisecretory | 0.137 0.033 CID_16304 | ||
| 0.176 | 0.021 | 0.18 | Carbonic anhydrase III inhibitor | 0.18 0.02 CID_16304 | CID_16304 | |
| 0.173 | 0.02 | 0.173 | Adenylate kinase inhibitor | 0.104 0.062 CID_16304 | ||
| 0.174 | 0.02 | 0.235 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.235 0.011 CID_16304 | CID_16304 | |
| 0.163 | 0.01 | 0.163 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.072 0.064 CID_16304 | ||
| 0.166 | 0.013 | 0.166 | NMDA 2 receptor antagonist | 0.09 0.037 CID_16304 | ||
| 0.268 | 0.115 | 0.268 | Transcription factor NF kappa B inhibitor | 0.262 0.119 CID_16304 | ||
| 0.155 | 0.005 | 0.155 | H+/K+-transporting ATPase inhibitor | 0.047 0.042 CID_16304 | ||
| 0.176 | 0.027 | 0.215 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.215 0.02 CID_16304 | CID_16304 | |
| 0.154 | 0.005 | 0.154 | Potassium channel (ATP-sensitive) blocker | 0.12 0.009 CID_16304 | ||
| 0.187 | 0.038 | 0.187 | Hemostatic | 0.153 0.064 CID_16304 | ||
| 0.212 | 0.063 | 0.212 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.162 | 0.014 | 0.162 | Inducible nitric-oxide synthase inhibitor | |||
| 0.196 | 0.049 | 0.196 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.176 | 0.029 | 0.176 | Adenylate cyclase stimulant | 0.13 0.101 CID_16304 | ||
| 0.185 | 0.04 | 0.185 | Nav1.2 sodium channel blocker | 0.151 0.056 CID_16304 | ||
| 0.166 | 0.021 | 0.171 | Heat shock protein 70 antagonist | 0.171 0.017 CID_16304 | CID_16304 | |
| 0.163 | 0.019 | 0.163 | Creatine kinase inhibitor | 0.114 0.046 CID_16304 | ||
| 0.212 | 0.068 | 0.212 | Death-associated protein kinase 3 inhibitor | 0.145 0.13 CID_16304 | ||
| 0.238 | 0.095 | 0.336 | Transcription factor STAT inhibitor | 0.336 0.039 CID_16304 | CID_16304 | |
| 0.207 | 0.064 | 0.212 | Focal adhesion kinase 2 inhibitor | 0.212 0.06 CID_16304 | CID_16304 | |
| 0.185 | 0.044 | 0.185 | Ribosomal protein S6 kinase inhibitor | |||
| 0.258 | 0.117 | 0.294 | Angiogenesis inhibitor | 0.294 0.096 CID_16304 | CID_16304 | |
| 0.159 | 0.019 | 0.159 | Carbonic anhydrase VI inhibitor | 0.113 0.032 CID_16304 | ||
| 0.215 | 0.078 | 0.221 | EphB2 antagonist | 0.221 0.074 CID_16304 | CID_16304 | |
| 0.189 | 0.053 | 0.284 | Cytidine deaminase inhibitor | 0.284 0.022 CID_16304 | CID_16304 | |
| 0.16 | 0.025 | 0.186 | TRPA1 agonist | 0.186 0.014 CID_16304 | CID_16304 | |
| 0.184 | 0.05 | 0.184 | Protein kinase (CK1) gamma inhibitor | 0.107 0.106 CID_16304 | ||
| 0.313 | 0.18 | 0.381 | Caspase 9 stimulant | 0.381 0.123 CID_16304 | CID_16304 | |
| 0.194 | 0.061 | 0.194 | Amyloid beta precursor protein antagonist | |||
| 0.159 | 0.027 | 0.212 | Papain-like protease (SARS coronavirus) inhibitor | 0.212 0.008 CID_16304 | CID_16304 | |
| 0.172 | 0.04 | 0.172 | MAP kinase kinase inhibitor | |||
| 0.19 | 0.059 | 0.19 | Tumour necrosis factor antagonist | 0.141 0.112 CID_16304 | ||
| 0.181 | 0.05 | 0.181 | Interferon gamma antagonist | 0.163 0.063 CID_16304 | ||
| 0.152 | 0.022 | 0.152 | Transcription factor STAT6 inhibitor | 0.143 0.029 CID_16304 | ||
| 0.208 | 0.077 | 0.208 | Anticonvulsant | |||
| 0.193 | 0.064 | 0.193 | Sigma receptor agonist | 0.148 0.087 CID_16304 | ||
| 0.147 | 0.017 | 0.147 | CYP2A6 inhibitor | |||
| 0.146 | 0.018 | 0.146 | MAP kinase kinase 1 inhibitor | 0.103 0.053 CID_16304 | ||
| 0.214 | 0.087 | 0.214 | Angiogenesis stimulant | |||
| 0.17 | 0.043 | 0.17 | Toll-Like receptor antagonist | |||
| 0.237 | 0.113 | 0.237 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.163 | 0.041 | 0.163 | Nav1.6 sodium channel blocker | |||
| 0.135 | 0.014 | 0.135 | Glutamate release inhibitor | |||
| 0.129 | 0.01 | 0.129 | Purinergic P2X1 antagonist | 0.062 0.04 CID_16304 | ||
| 0.126 | 0.008 | 0.126 | Estrogen-related receptor beta agonist | 0.09 0.04 CID_16304 | ||
| 0.14 | 0.021 | 0.14 | Histidine decarboxylase inhibitor | |||
| 0.161 | 0.044 | 0.161 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.129 | 0.012 | 0.129 | T cell inhibitor | 0.101 0.024 CID_16304 | ||
| 0.136 | 0.02 | 0.136 | Histamine N-methyltransferase inhibitor | |||
| 0.145 | 0.03 | 0.145 | Potassium channel (Ca-activated) activator | |||
| 0.249 | 0.134 | 0.344 | Thioredoxin glutathione reductase inhibitor | 0.344 0.079 CID_16304 | CID_16304 | |
| 0.151 | 0.037 | 0.151 | Microtubule formation inhibitor | 0.112 0.07 CID_16304 | ||
| 0.133 | 0.021 | 0.16 | Potassium channel (Voltage-sensitive) activator | 0.16 0.01 CID_16304 | CID_16304 | |
| 0.228 | 0.116 | 0.242 | Streptokinase A inhibitor | 0.242 0.108 CID_16304 | CID_16304 | |
| 0.131 | 0.021 | 0.131 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.124 | 0.014 | 0.124 | Granulocyte macrophage colony stimulating factor agonist | 0.083 0.066 CID_16304 | ||
| 0.139 | 0.029 | 0.159 | Urease inhibitor | 0.159 0.019 CID_16304 | CID_16304 | |
| 0.138 | 0.029 | 0.138 | DOPA decarboxylase inhibitor | |||
| 0.116 | 0.007 | 0.116 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.072 0.053 CID_16304 | ||
| 0.152 | 0.044 | 0.152 | Adenylate cyclase inhibitor | |||
| 0.161 | 0.054 | 0.186 | Cytokine production inhibitor | 0.186 0.041 CID_16304 | CID_16304 | |
| 0.117 | 0.01 | 0.155 | NMDA receptor glycine site agonist | 0.155 0.004 CID_16304 | CID_16304 | |
| 0.127 | 0.021 | 0.127 | Glutamate dehydrogenase inhibitor | 0.091 0.036 CID_16304 | ||
| 0.122 | 0.016 | 0.122 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.159 | 0.053 | 0.159 | Neuropeptide Y1 antagonist | 0.157 0.055 CID_16304 | ||
| 0.145 | 0.04 | 0.145 | Aminopeptidase B inhibitor | 0.11 0.058 CID_16304 | ||
| 0.114 | 0.01 | 0.114 | NMDA 2A receptor antagonist | 0.053 0.035 CID_16304 | ||
| 0.154 | 0.052 | 0.19 | NADPH oxidase inhibitor | 0.19 0.038 CID_16304 | CID_16304 | |
| 0.15 | 0.048 | 0.2 | Cyclooxygenase 3 inhibitor | 0.2 0.019 CID_16304 | CID_16304 | |
| 0.116 | 0.015 | 0.116 | D-Ala-D-Ala ligase inhibitor | 0.09 0.045 CID_16304 | ||
| 0.264 | 0.164 | 0.264 | Antibacterial | |||
| 0.234 | 0.134 | 0.433 | Thyroid hormone antagonist | 0.433 0.047 CID_16304 | CID_16304 | |
| 0.113 | 0.015 | 0.157 | NMDA receptor agonist | 0.157 0.007 CID_16304 | CID_16304 | |
| 0.129 | 0.031 | 0.129 | Anabolic | 0.119 0.04 CID_16304 | ||
| 0.155 | 0.059 | 0.155 | MAP kinase 3 inhibitor | 0.155 0.06 CID_16304 | ||
| 0.102 | 0.006 | 0.102 | Transcription factor RelA inhibitor | 0.074 0.023 CID_16304 | ||
| 0.123 | 0.029 | 0.123 | Thioredoxin inhibitor | |||
| 0.114 | 0.02 | 0.114 | Phenylalanine 4-hydroxylase inhibitor | 0.065 0.051 CID_16304 | ||
| 0.141 | 0.047 | 0.168 | Protein kinase (CK2) alpha inhibitor | 0.168 0.033 CID_16304 | CID_16304 | |
| 0.122 | 0.029 | 0.122 | Carbonic anhydrase XIII inhibitor | 0.1 0.038 CID_16304 | ||
| 0.124 | 0.031 | 0.158 | Androgen antagonist | 0.158 0.02 CID_16304 | CID_16304 | |
| 0.102 | 0.01 | 0.102 | Glutamate (mGluR6) antagonist | 0.069 0.041 CID_16304 | ||
| 0.097 | 0.005 | 0.097 | Sodium/calcium exchanger inhibitor | |||
| 0.207 | 0.116 | 0.207 | Immunostimulant | 0.198 0.122 CID_16304 | ||
| 0.268 | 0.177 | 0.441 | Alpha-glucosidase inhibitor | 0.441 0.099 CID_16304 | CID_16304 | |
| 0.142 | 0.052 | 0.142 | Aldehyde dehydrogenase inhibitor | |||
| 0.136 | 0.046 | 0.136 | DNA repair enzyme inhibitor | 0.112 0.091 CID_16304 | ||
| 0.104 | 0.015 | 0.104 | Acyl-CoA dehydrogenase inhibitor | 0.064 0.03 CID_16304 | ||
| 0.094 | 0.006 | 0.132 | Dihydroorotate oxidase inhibitor | 0.132 0.003 CID_16304 | CID_16304 | |
| 0.115 | 0.027 | 0.115 | Phosphofructokinase-1 inhibitor | |||
| 0.127 | 0.038 | 0.127 | Acetylcholine release stimulant | 0.102 0.083 CID_16304 | ||
| 0.12 | 0.032 | 0.19 | Potassium channel activator | 0.19 0.01 CID_16304 | CID_16304 | |
| 0.099 | 0.011 | 0.099 | Glutamate (mGluR7) antagonist | 0.07 0.043 CID_16304 | ||
| 0.201 | 0.113 | 0.266 | Calpain inhibitor | 0.266 0.051 CID_16304 | CID_16304 | |
| 0.105 | 0.017 | 0.105 | Alcohol oxidase inhibitor | 0.085 0.022 CID_16304 | ||
| 0.158 | 0.071 | 0.158 | Diuretic | 0.124 0.101 CID_16304 | ||
| 0.09 | 0.003 | 0.09 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.019 CID_16304 | ||
| 0.284 | 0.198 | 0.284 | MAP kinase 1 inhibitor | 0.276 0.206 CID_16304 | ||
| 0.099 | 0.013 | 0.099 | MAP kinase kinase 7 inhibitor | 0.083 0.038 CID_16304 | ||
| 0.222 | 0.137 | 0.429 | Thyroid hormone beta antagonist | 0.429 0.045 CID_16304 | CID_16304 | |
| 0.118 | 0.032 | 0.118 | ABCA1 expression enhancer | |||
| 0.104 | 0.019 | 0.104 | Glycine receptor agonist | 0.066 0.062 CID_16304 | ||
| 0.099 | 0.014 | 0.099 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.051 0.047 CID_16304 | ||
| 0.132 | 0.048 | 0.132 | Interleukin 8 antagonist | 0.101 0.094 CID_16304 | ||
| 0.136 | 0.052 | 0.136 | Beta amyloid protein antagonist | |||
| 0.092 | 0.008 | 0.092 | Potassium channel (Inward rectifier) blocker | 0.069 0.018 CID_16304 | ||
| 0.103 | 0.02 | 0.103 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.139 | 0.057 | 0.139 | M18 aspartyl aminopeptidase inhibitor | 0.111 0.079 CID_16304 | ||
| 0.129 | 0.047 | 0.142 | Mucolytic | 0.142 0.037 CID_16304 | CID_16304 | |
| 0.094 | 0.012 | 0.107 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.107 0.009 CID_16304 | CID_16304 | |
| 0.135 | 0.053 | 0.135 | Monophenol monooxygenase inhibitor | 0.111 0.068 CID_16304 | ||
| 0.108 | 0.027 | 0.108 | Myeloperoxidase inhibitor | |||
| 0.101 | 0.021 | 0.122 | CC chemokine 5 receptor agonist | 0.122 0.008 CID_16304 | CID_16304 | |
| 0.111 | 0.032 | 0.114 | Bcr-Abl kinase inhibitor | 0.114 0.03 CID_16304 | CID_16304 | |
| 0.098 | 0.019 | 0.098 | Argininosuccinate synthase inhibitor | |||
| 0.175 | 0.096 | 0.175 | Psychostimulant | |||
| 0.116 | 0.038 | 0.116 | NMDA receptor antagonist | |||
| 0.231 | 0.153 | 0.231 | Vasodilator, coronary | |||
| 0.108 | 0.033 | 0.108 | Bile acid receptor antagonist | 0.1 0.049 CID_16304 | ||
| 0.102 | 0.027 | 0.102 | Aminopeptidase I inhibitor | 0.086 0.037 CID_16304 | ||
| 0.203 | 0.129 | 0.322 | Transcription factor STAT3 inhibitor | 0.322 0.044 CID_16304 | CID_16304 | |
| 0.141 | 0.067 | 0.141 | Alkaline phosphatase inhibitor | 0.14 0.067 CID_16304 | ||
| 0.145 | 0.071 | 0.145 | Cell wall synthesis inhibitor | 0.139 0.076 CID_16304 | ||
| 0.085 | 0.011 | 0.085 | Calcium channel P-type blocker | |||
| 0.194 | 0.121 | 0.194 | DNA damaging | |||
| 0.137 | 0.065 | 0.137 | Tubulin antagonist | |||
| 0.106 | 0.034 | 0.106 | Bromodomain-containing protein 2 inhibitor | 0.101 0.039 CID_16304 | ||
| 0.15 | 0.079 | 0.151 | Cyclin-dependent kinase 8 inhibitor | 0.151 0.078 CID_16304 | CID_16304 | |
| 0.09 | 0.019 | 0.09 | Carbonic anhydrase VB inhibitor | 0.073 0.026 CID_16304 | ||
| 0.123 | 0.052 | 0.178 | Falcipain 3 inhibitor | 0.178 0.025 CID_16304 | CID_16304 | |
| 0.079 | 0.008 | 0.079 | Estrogen-related receptor alpha antagonist | |||
| 0.14 | 0.069 | 0.14 | Toll-Like receptor 9 antagonist | |||
| 0.079 | 0.008 | 0.079 | Adenylate cyclase 1 inhibitor | 0.051 0.026 CID_16304 | ||
| 0.135 | 0.065 | 0.261 | M17 leucyl aminopeptidase inhibitor | 0.261 0.018 CID_16304 | CID_16304 | |
| 0.074 | 0.004 | 0.074 | Glutamate (mGluR8) agonist | 0.051 0.011 CID_16304 | ||
| 0.086 | 0.018 | 0.086 | Alpha tubulin antagonist | |||
| 0.121 | 0.053 | 0.121 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.146 | 0.078 | 0.146 | Acetylcholine M1 receptor antagonist | |||
| 0.08 | 0.012 | 0.08 | NMDA receptor subunit 3A antagonist | |||
| 0.142 | 0.074 | 0.142 | Lipid peroxidase inhibitor | |||
| 0.072 | 0.006 | 0.072 | Dihydrofolate reductase inhibitor | |||
| 0.132 | 0.066 | 0.19 | Toll-Like receptor 2 antagonist | 0.19 0.028 CID_16304 | CID_16304 | |
| 0.075 | 0.009 | 0.075 | Fructose-1,6-bisphosphatase inhibitor | 0.044 0.032 CID_16304 | ||
| 0.077 | 0.011 | 0.077 | Ryanodine receptor antagonist | |||
| 0.085 | 0.021 | 0.085 | Alpha 2 adrenoreceptor agonist | 0.054 0.051 CID_16304 | ||
| 0.07 | 0.005 | 0.07 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.117 | 0.053 | 0.117 | Expectorant | 0.115 0.054 CID_16304 | ||
| 0.09 | 0.026 | 0.09 | GABA B receptor agonist | 0.083 0.037 CID_16304 | ||
| 0.105 | 0.043 | 0.105 | Phosphodiesterase 6D inhibitor | 0.094 0.066 CID_16304 | ||
| 0.095 | 0.033 | 0.095 | Interferon agonist | |||
| 0.087 | 0.025 | 0.087 | MAP kinase 7 inhibitor | |||
| 0.153 | 0.091 | 0.153 | CDC-like kinase 2 inhibitor | |||
| 0.09 | 0.03 | 0.098 | Carbonic anhydrase VA inhibitor | 0.098 0.026 CID_16304 | CID_16304 | |
| 0.082 | 0.022 | 0.082 | Exportin-1 inhibitor | |||
| 0.074 | 0.015 | 0.074 | Topoisomerase II beta inhibitor | 0.063 0.02 CID_16304 | ||
| 0.082 | 0.023 | 0.082 | Androgen agonist | 0.064 0.036 CID_16304 | ||
| 0.093 | 0.034 | 0.093 | Glutamate decarboxylase inhibitor | |||
| 0.146 | 0.087 | 0.146 | Melanin inhibitor | 0.131 0.113 CID_16304 | ||
| 0.068 | 0.009 | 0.068 | Geranyltranstransferase inhibitor | |||
| 0.075 | 0.016 | 0.075 | Aconitate hydratase inhibitor | |||
| 0.07 | 0.012 | 0.07 | Thymidylate synthase inhibitor | |||
| 0.096 | 0.039 | 0.096 | mTOR complex 2 inhibitor | |||
| 0.12 | 0.063 | 0.157 | Interleukin 1b antagonist | 0.157 0.036 CID_16304 | CID_16304 | |
| 0.081 | 0.024 | 0.081 | Maillard reaction inhibitor | 0.051 0.042 CID_16304 | ||
| 0.065 | 0.009 | 0.065 | Alpha 1d adrenoreceptor agonist | 0.052 0.015 CID_16304 | ||
| 0.122 | 0.066 | 0.122 | Alkylator | 0.099 0.09 CID_16304 | ||
| 0.088 | 0.032 | 0.101 | Carbonic anhydrase V inhibitor | 0.101 0.027 CID_16304 | CID_16304 | |
| 0.064 | 0.01 | 0.064 | Dihydropteroate synthase inhibitor | 0.048 0.018 CID_16304 | ||
| 0.077 | 0.023 | 0.077 | MDM2 inhibitor | |||
| 0.074 | 0.021 | 0.077 | Botulinum neurotoxin type A inhibitor | 0.077 0.019 CID_16304 | CID_16304 | |
| 0.061 | 0.008 | 0.061 | Potassium channel Kv1.1 blocker | 0.059 0.009 CID_16304 | ||
| 0.082 | 0.029 | 0.082 | Beta tubulin antagonist | |||
| 0.084 | 0.032 | 0.084 | Secretase beta inhibitor | 0.071 0.048 CID_16304 | ||
| 0.071 | 0.02 | 0.071 | Phosphorylase inhibitor | 0.066 0.022 CID_16304 | ||
| 0.078 | 0.026 | 0.078 | Interferon inducer | |||
| 0.126 | 0.074 | 0.126 | Vanilloid 1 agonist | 0.123 0.081 CID_16304 | ||
| 0.065 | 0.014 | 0.065 | Kainate receptor antagonist | |||
| 0.061 | 0.01 | 0.061 | Guanylate cyclase inhibitor | |||
| 0.106 | 0.055 | 0.128 | Platelet activating factor alpha antagonist | 0.128 0.04 CID_16304 | CID_16304 | |
| 0.101 | 0.051 | 0.101 | Alcohol dehydrogenase inhibitor | |||
| 0.092 | 0.042 | 0.092 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.065 | 0.015 | 0.065 | Glucose-6-phosphate isomerase inhibitor | 0.058 0.02 CID_16304 | ||
| 0.132 | 0.082 | 0.132 | Activin receptor-like kinase 2 inhibitor | |||
| 0.152 | 0.102 | 0.177 | DNA methyltransferase I inhibitor | 0.177 0.082 CID_16304 | CID_16304 | |
| 0.106 | 0.057 | 0.106 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.062 | 0.013 | 0.062 | AICAR transformylase inhibitor | 0.053 0.019 CID_16304 | ||
| 0.212 | 0.163 | 0.235 | Vasodilator, peripheral | 0.235 0.139 CID_16304 | CID_16304 | |
| 0.077 | 0.029 | 0.077 | Aryl hydrocarbon receptor antagonist | 0.068 0.04 CID_16304 | ||
| 0.093 | 0.046 | 0.093 | MAP-kinase-activated kinase inhibitor | |||
| 0.051 | 0.005 | 0.051 | Glutamate (mGluR1a) agonist | 0.03 0.009 CID_16304 | ||
| 0.182 | 0.135 | 0.182 | Spasmolytic | |||
| 0.103 | 0.057 | 0.103 | Insulin receptor antagonist | |||
| 0.066 | 0.021 | 0.066 | Lysine-specific demethylase 1A inhibitor | |||
| 0.105 | 0.061 | 0.105 | MAO A inhibitor | 0.086 0.075 CID_16304 | ||
| 0.073 | 0.029 | 0.073 | Carbonic anhydrase stimulant | 0.069 0.032 CID_16304 | ||
| 0.075 | 0.031 | 0.075 | Aromatase inhibitor | |||
| 0.075 | 0.031 | 0.075 | 5 Hydroxytryptamine 3 agonist | |||
| 0.084 | 0.04 | 0.084 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.059 | 0.015 | 0.059 | Histamine H2 receptor agonist | 0.043 0.03 CID_16304 | ||
| 0.104 | 0.06 | 0.12 | Protein kinase (CK2) inhibitor | 0.12 0.048 CID_16304 | CID_16304 | |
| 0.133 | 0.09 | 0.148 | Pregnane X receptor agonist | 0.148 0.056 CID_16304 | CID_16304 | |
| 0.047 | 0.005 | 0.05 | Adenosine uptake inhibitor | 0.05 0.005 CID_16304 | CID_16304 | |
| 0.079 | 0.037 | 0.079 | Phospholipase D inhibitor | |||
| 0.145 | 0.105 | 0.145 | CDC-like kinase 4 inhibitor | |||
| 0.085 | 0.045 | 0.085 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.067 | 0.026 | 0.102 | Acetyl-CoA transferase inhibitor | 0.102 0.013 CID_16304 | CID_16304 | |
| 0.053 | 0.013 | 0.053 | Retinoid X alpha receptor agonist | |||
| 0.075 | 0.035 | 0.075 | Histone deacetylase inhibitor | 0.062 0.05 CID_16304 | ||
| 0.114 | 0.074 | 0.114 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.191 | 0.15 | 0.191 | Lipoxygenase inhibitor | |||
| 0.054 | 0.014 | 0.074 | Delayed rectifier potassium channel activator | 0.074 0.006 CID_16304 | CID_16304 | |
| 0.054 | 0.014 | 0.074 | Potassium channel KCNQ activator | 0.074 0.006 CID_16304 | CID_16304 | |
| 0.054 | 0.015 | 0.054 | Dopamine D5 agonist | |||
| 0.054 | 0.014 | 0.054 | Nerve growth factor antagonist | 0.049 0.02 CID_16304 | ||
| 0.066 | 0.026 | 0.066 | Toll-Like receptor 8 antagonist | |||
| 0.145 | 0.106 | 0.145 | TRKC antagonist | |||
| 0.113 | 0.074 | 0.113 | Abl kinase inhibitor | |||
| 0.061 | 0.022 | 0.061 | Immunoglobulin Fc receptor antagonist | 0.054 0.042 CID_16304 | ||
| 0.056 | 0.018 | 0.056 | Cytokine production stimulant | |||
| 0.052 | 0.014 | 0.052 | Vascular adhesion protein 1 inhibitor | |||
| 0.162 | 0.125 | 0.162 | Dyrk kinase inhibitor | |||
| 0.092 | 0.055 | 0.092 | Pim-3 kinase inhibitor | |||
| 0.054 | 0.017 | 0.054 | Glutamate (mGluR group III) antagonist | |||
| 0.078 | 0.041 | 0.078 | Purinergic P2X2 antagonist | |||
| 0.084 | 0.047 | 0.084 | Na+ K+ transporting ATPase inhibitor | |||
| 0.053 | 0.017 | 0.053 | Retinoid X receptor agonist | |||
| 0.091 | 0.055 | 0.091 | Ornithine decarboxylase inhibitor | |||
| 0.066 | 0.032 | 0.066 | Heat shock protein 90 beta antagonist | 0.054 0.052 CID_16304 | ||
| 0.059 | 0.025 | 0.059 | Carbonic anhydrase XIV inhibitor | 0.048 0.036 CID_16304 | ||
| 0.111 | 0.076 | 0.111 | TRKA antagonist | |||
| 0.098 | 0.064 | 0.123 | Glutamate (mGluR7) agonist | 0.123 0.027 CID_16304 | CID_16304 | |
| 0.049 | 0.015 | 0.049 | Heme oxygenase inhibitor | |||
| 0.049 | 0.015 | 0.049 | Inosine monophosphate dehydrogenase inhibitor | 0.044 0.019 CID_16304 | ||
| 0.067 | 0.033 | 0.083 | Histone deacetylase SIRT3 inhibitor | 0.083 0.016 CID_16304 | CID_16304 | |
| 0.059 | 0.026 | 0.069 | Glycine transporter 2 inhibitor | 0.069 0.021 CID_16304 | CID_16304 | |
| 0.149 | 0.116 | 0.149 | Non-steroidal antiinflammatory agent | |||
| 0.084 | 0.051 | 0.117 | Glycine receptor antagonist | 0.117 0.02 CID_16304 | CID_16304 | |
| 0.061 | 0.028 | 0.061 | Pregnane X receptor antagonist | 0.055 0.044 CID_16304 | ||
| 0.157 | 0.124 | 0.163 | Insulin sensitizer | 0.163 0.116 CID_16304 | CID_16304 | |
| 0.056 | 0.024 | 0.056 | Adenosine deaminase inhibitor | |||
| 0.08 | 0.048 | 0.08 | Keratolytic | |||
| 0.086 | 0.054 | 0.086 | Histamine H2 receptor antagonist | |||
| 0.065 | 0.034 | 0.065 | Glutamate (mGluR1) antagonist | |||
| 0.06 | 0.029 | 0.06 | Epithelial sodium channel blocker | |||
| 0.1 | 0.069 | 0.11 | Beta glucuronidase inhibitor | 0.11 0.056 CID_16304 | CID_16304 | |
| 0.053 | 0.022 | 0.053 | Glutamate (mGluR group III) agonist | |||
| 0.035 | 0.005 | 0.035 | Complement factor 1s inhibitor | |||
| 0.076 | 0.045 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.045 CID_16304 | ||
| 0.053 | 0.023 | 0.053 | NMDA receptor subunit 3B antagonist | 0.044 0.03 CID_16304 | ||
| 0.057 | 0.027 | 0.057 | AMPA receptor antagonist | |||
| 0.065 | 0.035 | 0.106 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.106 0.015 CID_16304 | CID_16304 | |
| 0.047 | 0.017 | 0.047 | AMPA 4 receptor antagonist | |||
| 0.056 | 0.026 | 0.064 | Potassium channel (Inward rectifier) activator | 0.064 0.015 CID_16304 | CID_16304 | |
| 0.05 | 0.02 | 0.05 | Glutamate (mGluR4) antagonist | |||
| 0.066 | 0.036 | 0.066 | Phosphodiesterase 1C inhibitor | |||
| 0.037 | 0.007 | 0.037 | Estrogen-related receptor gamma antagonist | 0.028 0.021 CID_16304 | ||
| 0.065 | 0.036 | 0.065 | Corticotropin releasing factor 2 receptor antagonist | 0.059 0.048 CID_16304 | ||
| 0.064 | 0.035 | 0.064 | Beta 2 adrenoreceptor agonist | 0.059 0.052 CID_16304 | ||
| 0.053 | 0.025 | 0.061 | Potassium channel (ATP-sensitive) activator | 0.061 0.015 CID_16304 | CID_16304 | |
| 0.033 | 0.006 | 0.033 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.052 | 0.026 | 0.052 | Dopamine beta hydroxylase inhibitor | |||
| 0.048 | 0.022 | 0.048 | Glutamate (mGluR1a) antagonist | |||
| 0.091 | 0.065 | 0.091 | Prolactin inhibitor | |||
| 0.047 | 0.021 | 0.047 | Thymidine kinase inhibitor | |||
| 0.048 | 0.022 | 0.048 | Histamine H1 receptor agonist | |||
| 0.161 | 0.135 | 0.161 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.11 | 0.085 | 0.164 | Nav1.3 sodium channel blocker | 0.164 0.039 CID_16304 | CID_16304 | |
| 0.058 | 0.033 | 0.058 | Ornithine carbamoyltransferase inhibitor | |||
| 0.062 | 0.037 | 0.062 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.057 | 0.033 | 0.057 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.036 | 0.011 | 0.036 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.043 | 0.019 | 0.043 | Retinoid X receptor antagonist | |||
| 0.042 | 0.018 | 0.042 | Phosphoglycerate kinase inhibitor | |||
| 0.144 | 0.121 | 0.243 | Death-associated protein kinase 2 inhibitor | 0.243 0.015 CID_16304 | CID_16304 | |
| 0.037 | 0.013 | 0.037 | Glutamate (mGluR3) agonist | |||
| 0.049 | 0.026 | 0.09 | Dihydroorotase inhibitor | 0.09 0.007 CID_16304 | CID_16304 | |
| 0.03 | 0.007 | 0.03 | Imidazoline I1 receptor antagonist | 0.03 0.007 CID_16304 | ||
| 0.044 | 0.022 | 0.044 | Kainate receptor agonist | |||
| 0.057 | 0.035 | 0.057 | Sphingosine kinase 2 inhibitor | |||
| 0.039 | 0.017 | 0.039 | Purinergic P2Y2 antagonist | |||
| 0.074 | 0.052 | 0.078 | Adenosine A3 receptor antagonist | 0.078 0.046 CID_16304 | CID_16304 | |
| 0.03 | 0.008 | 0.03 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.02 0.013 CID_16304 | ||
| 0.041 | 0.02 | 0.041 | Glutamate (mGluR3) antagonist | |||
| 0.04 | 0.019 | 0.04 | Fumarate hydratase inhibitor | |||
| 0.039 | 0.017 | 0.039 | Glutamate (mGluR4) agonist | |||
| 0.033 | 0.012 | 0.033 | Purinergic P2Y15 antagonist | 0.029 0.019 CID_16304 | ||
| 0.032 | 0.011 | 0.038 | NMDA receptor glycine site antagonist | 0.038 0.009 CID_16304 | CID_16304 | |
| 0.092 | 0.071 | 0.092 | Ephrin antagonist | |||
| 0.06 | 0.039 | 0.069 | Sphingosine 1-phosphate receptor 3 antagonist | 0.069 0.026 CID_16304 | CID_16304 | |
| 0.038 | 0.017 | 0.038 | Retinoid X alpha receptor antagonist | |||
| 0.092 | 0.071 | 0.092 | Vascular endothelial growth factor 1 antagonist | |||
| 0.061 | 0.041 | 0.071 | Cyclin D1 inhibitor | 0.071 0.027 CID_16304 | CID_16304 | |
| 0.076 | 0.056 | 0.076 | Fibroblast growth factor 3 antagonist | |||
| 0.117 | 0.098 | 0.117 | Vascular endothelial growth factor 3 antagonist | |||
| 0.044 | 0.025 | 0.054 | Acetyl-CoA transferase 1 inhibitor | 0.054 0.013 CID_16304 | CID_16304 | |
| 0.041 | 0.022 | 0.044 | Diamine oxidase inhibitor | 0.044 0.019 CID_16304 | CID_16304 | |
| 0.104 | 0.086 | 0.104 | MAO inhibitor | |||
| 0.041 | 0.023 | 0.041 | TRPM8 blocker | |||
| 0.033 | 0.016 | 0.033 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.142 | 0.125 | 0.152 | DNA methylase inhibitor | 0.152 0.115 CID_16304 | CID_16304 | |
| 0.029 | 0.011 | 0.029 | Vanilloid 2 agonist | |||
| 0.079 | 0.062 | 0.079 | I kappa B kinase inhibitor | |||
| 0.024 | 0.007 | 0.024 | Alpha 2a adrenoreceptor agonist | |||
| 0.024 | 0.007 | 0.024 | Alpha 2c adrenoreceptor agonist | 0.023 0.008 CID_16304 | ||
| 0.023 | 0.007 | 0.023 | Estrogen-related receptor gamma agonist | 0.018 0.014 CID_16304 | ||
| 0.049 | 0.033 | 0.049 | CC chemokine receptor 2B antagonist | |||
| 0.2 | 0.185 | 0.473 | Beta lactamase inhibitor | 0.473 0.08 CID_16304 | CID_16304 | |
| 0.065 | 0.05 | 0.065 | Acetylcholine M5 receptor agonist | |||
| 0.063 | 0.048 | 0.071 | Protease 3C (Human rhinovirus) inhibitor | 0.071 0.035 CID_16304 | CID_16304 | |
| 0.029 | 0.014 | 0.029 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.059 | 0.044 | 0.059 | Acetylcholine M5 receptor antagonist | |||
| 0.041 | 0.026 | 0.041 | Histone deacetylase class I inhibitor | |||
| 0.043 | 0.029 | 0.043 | GABA B receptor antagonist | |||
| 0.023 | 0.009 | 0.023 | Retinoid X beta receptor antagonist | |||
| 0.033 | 0.02 | 0.033 | Potassium channel small-conductance Ca-activated activator | |||
| 0.037 | 0.023 | 0.037 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.032 | 0.019 | 0.032 | AMPA 3 receptor antagonist | |||
| 0.052 | 0.039 | 0.062 | Nicotinic alpha3beta2 receptor antagonist | 0.062 0.025 CID_16304 | CID_16304 | |
| 0.074 | 0.06 | 0.099 | Sphingosine 1-phosphate receptor antagonist | 0.099 0.022 CID_16304 | CID_16304 | |
| 0.052 | 0.039 | 0.052 | Alpha-mannosidase inhibitor | |||
| 0.072 | 0.059 | 0.074 | Vanilloid 4 agonist | 0.074 0.052 CID_16304 | CID_16304 | |
| 0.106 | 0.094 | 0.106 | Cyclooxygenase 1 inhibitor | |||
| 0.109 | 0.097 | 0.109 | Tyrosine-protein kinase receptor antagonist | |||
| 0.03 | 0.018 | 0.03 | CDK4/cyclin D3 inhibitor | |||
| 0.026 | 0.014 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.039 | 0.027 | 0.039 | 5 Hydroxytryptamine 2B agonist | |||
| 0.101 | 0.089 | 0.101 | c-Src kinase inhibitor | |||
| 0.016 | 0.005 | 0.016 | Glutamate (mGluR6) agonist | |||
| 0.045 | 0.034 | 0.059 | Carbonic anhydrase VII inhibitor | 0.059 0.019 CID_16304 | CID_16304 | |
| 0.141 | 0.129 | 0.141 | Catenin beta inhibitor | |||
| 0.072 | 0.061 | 0.072 | MAP kinase 10 inhibitor | |||
| 0.031 | 0.02 | 0.031 | Acetylcholine M4 receptor agonist | |||
| 0.093 | 0.082 | 0.093 | Alpha 2b adrenoreceptor antagonist | |||
| 0.049 | 0.038 | 0.06 | Lysophosphatidic acid 3 receptor antagonist | 0.06 0.023 CID_16304 | CID_16304 | |
| 0.085 | 0.075 | 0.085 | Protein kinase C zeta inhibitor | |||
| 0.137 | 0.127 | 0.137 | Clk dual-specificity kinase inhibitor | |||
| 0.052 | 0.043 | 0.052 | Glucosylceramidase inhibitor | |||
| 0.194 | 0.184 | 0.194 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.012 | 0.003 | 0.012 | DNA topoisomerase III inhibitor | 0.009 0.004 CID_16304 | ||
| 0.077 | 0.068 | 0.077 | Caspase 7 inhibitor | |||
| 0.054 | 0.045 | 0.054 | EphB4 antagonist | |||
| 0.059 | 0.05 | 0.059 | I kappa B kinase 2 inhibitor | |||
| 0.026 | 0.017 | 0.026 | Acid ceramidase inhibitor | |||
| 0.04 | 0.032 | 0.04 | Oxytocin agonist | |||
| 0.027 | 0.02 | 0.027 | Uridine phosphorylase inhibitor | |||
| 0.021 | 0.013 | 0.021 | Toll-Like receptor 8 agonist | |||
| 0.038 | 0.03 | 0.038 | Membrane dipeptidase inhibitor | |||
| 0.053 | 0.046 | 0.064 | Adenine nucleotide translocase inhibitor | 0.064 0.022 CID_16304 | CID_16304 | |
| 0.03 | 0.023 | 0.056 | Epoxide hydrolase 1 inhibitor | 0.056 0.005 CID_16304 | CID_16304 | |
| 0.017 | 0.01 | 0.017 | CDK2/cyclin A3 inhibitor | |||
| 0.026 | 0.019 | 0.026 | Thymidine phosphorylase inhibitor | |||
| 0.046 | 0.039 | 0.046 | Histamine H4 receptor antagonist | |||
| 0.121 | 0.115 | 0.123 | Phospholipase A2 inhibitor | 0.123 0.112 CID_16304 | CID_16304 | |
| 0.114 | 0.107 | 0.114 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.066 | 0.059 | 0.066 | Cathepsin G inhibitor | |||
| 0.061 | 0.054 | 0.061 | Alpha adrenoreceptor agonist | |||
| 0.029 | 0.023 | 0.029 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.089 | 0.083 | 0.122 | Mediator release inhibitor | 0.122 0.046 CID_16304 | CID_16304 | |
| 0.018 | 0.013 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.073 | 0.068 | 0.073 | Adrenaline agonist | |||
| 0.121 | 0.115 | 0.145 | Thiol protease inhibitor | 0.145 0.073 CID_16304 | CID_16304 | |
| 0.019 | 0.014 | 0.019 | Antibiotic Anthracycline-like | |||
| 0.072 | 0.068 | 0.072 | TIE antagonist | |||
| 0.045 | 0.04 | 0.048 | Benzodiazepine antagonist | 0.048 0.03 CID_16304 | CID_16304 | |
| 0.11 | 0.105 | 0.184 | Histone deacetylase SIRT1 inhibitor | 0.184 0.037 CID_16304 | CID_16304 | |
| 0.02 | 0.016 | 0.022 | Factor XIII inhibitor | 0.022 0.012 CID_16304 | CID_16304 | |
| 0.071 | 0.067 | 0.071 | TIE-2 antagonist | |||
| 0.1 | 0.096 | 0.1 | Glutamate receptor antagonist | |||
| 0.06 | 0.056 | 0.072 | Beta 3 adrenoreceptor antagonist | 0.072 0.031 CID_16304 | CID_16304 | |
| 0.017 | 0.013 | 0.017 | CC chemokine 9 receptor antagonist | |||
| 0.051 | 0.048 | 0.051 | Adenosine A1 receptor antagonist | |||
| 0.034 | 0.031 | 0.034 | Integrin alpha2 antagonist | |||
| 0.02 | 0.017 | 0.035 | Neuraminidase (Influenza B) inhibitor | 0.035 0.004 CID_16304 | CID_16304 | |
| 0.025 | 0.023 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.009 | 0.007 | 0.009 | Progesterone receptor A antagonist | |||
| 0.099 | 0.097 | 0.099 | Calcium channel N-type blocker | |||
| 0.024 | 0.022 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.015 | 0.012 | 0.015 | Purinergic P2Y1 agonist | |||
| 0.01 | 0.008 | 0.01 | Imidazoline I2 receptor antagonist | |||
| 0.096 | 0.094 | 0.096 | Nav1.5 sodium channel blocker | |||
| 0.049 | 0.047 | 0.07 | Heparanase inhibitor | 0.07 0.012 CID_16304 | CID_16304 | |
| 0.014 | 0.013 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.024 | 0.023 | 0.031 | Thyroid hormone agonist | 0.031 0.011 CID_16304 | CID_16304 | |
| 0.047 | 0.045 | 0.047 | Carbonic anhydrase IX inhibitor | |||
| 0.059 | 0.058 | 0.059 | CDC7 inhibitor | |||
| 0.062 | 0.061 | 0.111 | Prostaglandin-E synthase inhibitor | 0.111 0.022 CID_16304 | CID_16304 | |
| 0.016 | 0.015 | 0.016 | Telomerase stimulant | |||
| 0.025 | 0.024 | 0.025 | Thrombin receptor antagonist | |||
| 0.021 | 0.02 | 0.021 | Histone deacetylase 1 inhibitor | |||
| 0.051 | 0.05 | 0.051 | Kallikrein 1 inhibitor | |||
| 0.063 | 0.062 | 0.069 | MAP kinase 14 inhibitor | 0.069 0.056 CID_16304 | CID_16304 | |
| 0.074 | 0.074 | 0.112 | Stem cell growth factor agonist | 0.112 0.036 CID_16304 | CID_16304 | |
| 0.012 | 0.013 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.006 CID_16304 | CID_16304 | |
| 0.026 | 0.029 | 0.032 | Lysophosphatidic acid 2 receptor antagonist | 0.032 0.019 CID_16304 | CID_16304 | |
| 0.027 | 0.032 | 0.036 | Methionyl aminopeptidase 1 inhibitor | 0.036 0.016 CID_16304 | CID_16304 | |
| 0.034 | 0.038 | 0.043 | MAP3K5 inhibitor | 0.043 0.021 CID_16304 | CID_16304 | |
| 0.023 | 0.028 | 0.029 | Nicotinic acid receptor 2 antagonist | 0.029 0.014 CID_16304 | CID_16304 | |
| 0.042 | 0.047 | 0.095 | Dihydroorotate dehydrogenase inhibitor | 0.095 0.013 CID_16304 | CID_16304 | |
| 0.018 | 0.023 | 0.03 | Protease (Human cytomegalovirus) inhibitor | 0.03 0.008 CID_16304 | CID_16304 | |
| 0.105 | 0.11 | 0.141 | Antibacterial (Helicobacter pylori) | 0.141 0.054 CID_16304 | CID_16304 | |
| 0.013 | 0.018 | 0.024 | Carbonic anhydrase X inhibitor | 0.024 0.006 CID_16304 | CID_16304 | |
| 0.013 | 0.018 | 0.024 | Carbonic anhydrase VIII inhibitor | 0.024 0.006 CID_16304 | CID_16304 | |
| 0.05 | 0.056 | 0.062 | Sphingosine 1-phosphate receptor 1 antagonist | 0.062 0.027 CID_16304 | CID_16304 | |
| 0.052 | 0.06 | 0.064 | p38 MAP kinase inhibitor | 0.064 0.048 CID_16304 | CID_16304 | |
| 0.01 | 0.018 | 0.016 | Human herpes virus 5 capsid protein P40 inhibitor | 0.016 0.005 CID_16304 | CID_16304 | |
| 0.125 | 0.134 | 0.143 | Antipruritic | 0.143 0.102 CID_16304 | CID_16304 | |
| 0.009 | 0.019 | 0.015 | Carbonic anhydrase XI inhibitor | 0.015 0.006 CID_16304 | CID_16304 | |
| 0.041 | 0.052 | 0.051 | Carbonic anhydrase I inhibitor | 0.051 0.043 CID_16304 | CID_16304 | |
| 0.033 | 0.043 | 0.045 | Carbonic anhydrase IV inhibitor | 0.045 0.028 CID_16304 | CID_16304 | |
| 0.021 | 0.032 | 0.024 | Calcium-sensing receptor agonist | 0.024 0.022 CID_16304 | CID_16304 | |
| 0.112 | 0.125 | 0.131 | Farnesoid X receptor antagonist | 0.131 0.081 CID_16304 | CID_16304 | |
| 0.031 | 0.045 | 0.064 | CDK5/p25 inhibitor | 0.064 0.014 CID_16304 | CID_16304 | |
| 0.012 | 0.027 | 0.02 | Nicotinic acid receptor 1 antagonist | 0.02 0.009 CID_16304 | CID_16304 | |
| 0.055 | 0.071 | 0.149 | Catalase inhibitor | 0.149 0.026 CID_16304 | CID_16304 | |
| 0.095 | 0.112 | 0.11 | Interleukin 2 antagonist | 0.11 0.063 CID_16304 | CID_16304 | |
| 0.032 | 0.051 | 0.038 | Leukocyte elastase inhibitor | 0.038 0.036 CID_16304 | CID_16304 | |
| 0.077 | 0.101 | 0.099 | Interleukin 1 beta converting enzyme inhibitor | 0.099 0.059 CID_16304 | CID_16304 | |
| 0.054 | 0.08 | 0.068 | Telomerase inhibitor | 0.068 0.054 CID_16304 | CID_16304 | |
| 0.043 | 0.07 | 0.073 | Fatty acid synthase inhibitor | 0.073 0.023 CID_16304 | CID_16304 | |
| 0.015 | 0.043 | 0.025 | Cyclin E2 inhibitor | 0.025 0.024 CID_16304 | CID_16304 | |
| 0.022 | 0.05 | 0.055 | Nicotinic acid receptor agonist | 0.055 0.013 CID_16304 | CID_16304 | |
| 0.008 | 0.036 | 0.015 | 5-Alpha-reductase 1 inhibitor | 0.015 0.013 CID_16304 | CID_16304 | |
| 0.048 | 0.077 | 0.054 | Leukotriene C antagonist | 0.054 0.049 CID_16304 | CID_16304 | |
| 0.065 | 0.095 | 0.079 | Glutathione S-transferase inhibitor | 0.079 0.063 CID_16304 | CID_16304 | |
| 0.021 | 0.051 | 0.034 | 5-Alpha-reductase inhibitor | 0.034 0.03 CID_16304 | CID_16304 | |
| 0.025 | 0.056 | 0.046 | Histone deacetylase 8 inhibitor | 0.046 0.024 CID_16304 | CID_16304 | |
| 0.023 | 0.056 | 0.034 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.034 0.024 CID_16304 | CID_16304 | |
| 0.08 | 0.118 | 0.119 | Proteasome inhibitor | 0.119 0.066 CID_16304 | CID_16304 | |
| 0.083 | 0.125 | 0.132 | Caspase 3 inhibitor | 0.132 0.044 CID_16304 | CID_16304 | |
| 0.049 | 0.1 | 0.083 | Epoxide hydrolase inhibitor | 0.083 0.039 CID_16304 | CID_16304 | |
| 0.161 | 0.214 | 0.187 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.187 0.173 CID_16304 | CID_16304 | |
| 0.034 | 0.098 | 0.061 | TRPA1 antagonist | 0.061 0.042 CID_16304 | CID_16304 | |
| 0.04 | 0.121 | 0.097 | Histone deacetylase SIRT2 inhibitor | 0.097 0.032 CID_16304 | CID_16304 | |
| 0.075 | 0.162 | 0.163 | CDK3/cyclin E inhibitor | 0.163 0.019 CID_16304 | CID_16304 | |
| 0.071 | 0.162 | 0.119 | Hedgehog signaling inhibitor | 0.119 0.04 CID_16304 | CID_16304 | |
| 0.032 | 0.13 | 0.077 | Vanilloid antagonist | 0.077 0.049 CID_16304 | CID_16304 | |
| 0.062 | 0.162 | 0.141 | Histone deacetylase class III inhibitor | 0.141 0.051 CID_16304 | CID_16304 | |
| 0.09 | 0.192 | 0.138 | NOS3 expression enhancer | 0.138 0.085 CID_16304 | CID_16304 | |
| 0.018 | 0.14 | 0.063 | Smo receptor antagonist | 0.063 0.018 CID_16304 | CID_16304 | |
| 0.01 | 0.136 | 0.021 | Potassium channel (Inward rectifier) 11 blocker | 0.021 0.008 CID_16304 | CID_16304 | |
| 0.069 | 0.205 | 0.11 | Interleukin 4 antagonist | 0.11 0.101 CID_16304 | CID_16304 | |
| 0.084 | 0.226 | 0.253 | Interleukin antagonist | 0.253 0.06 CID_16304 | CID_16304 | |
| 0.045 | 0.199 | 0.078 | Cell adhesion molecule inhibitor | 0.078 0.055 CID_16304 | CID_16304 | |
| 0.031 | 0.198 | 0.05 | DNA helicase inhibitor | 0.05 0.048 CID_16304 | CID_16304 | |
| 0.011 | 0.2 | 0.028 | Cyclophilin A inhibitor | 0.028 0.027 CID_16304 | CID_16304 | |
| 0.023 | 0.211 | 0.188 | Neuraminidase (influenza) inhibitor | 0.188 0.005 CID_16304 | CID_16304 | |
| 0.086 | 0.291 | 0.123 | Death-associated protein kinase 1 inhibitor | 0.123 0.101 CID_16304 | CID_16304 | |
| 0.014 | 0.223 | 0.17 | Neuraminidase inhibitor | 0.17 0.005 CID_16304 | CID_16304 | |
| 0.015 | 0.228 | 0.083 | Neuraminidase (Influenza A) inhibitor | 0.083 0.005 CID_16304 | CID_16304 | |
| 0.039 | 0.273 | 0.079 | Falcipain 2 inhibitor | 0.079 0.07 CID_16304 | CID_16304 | |
| 0.039 | 0.279 | 0.083 | Falcipain inhibitor | 0.083 0.07 CID_16304 | CID_16304 | |
| 0.015 | 0.258 | 0.039 | Nicotinic acid receptor 1 agonist | 0.039 0.03 CID_16304 | CID_16304 | |
| 0.049 | 0.299 | 0.101 | Cell adhesion inhibitor | 0.101 0.087 CID_16304 | CID_16304 | |
| 0.109 | 0.368 | 0.223 | Peptidyltransferase inhibitor | 0.223 0.074 CID_16304 | CID_16304 | |
| 0.049 | 0.359 | 0.124 | Aurora-C kinase inhibitor | 0.124 0.097 CID_16304 | CID_16304 | |
| 0.055 | 0.679 | 0.145 | Cyclin-dependent kinase 3 inhibitor | 0.145 0.11 CID_16304 | CID_16304 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |